Oncology Treatment Tourism Market Report 2026

Oncology Treatment Tourism Market Overview

• Oncology Treatment Tourism market size has reached to $6.99 billion in 2025 • Expected to grow to $11.54 billion in 2030 at a compound annual growth rate (CAGR) of 10.6% • Growth Driver: Increasing Prevalence Of Cancer Fueling The Growth Of The Market Due To Rising Incidence Rates And Expanding Treatment Demand • Market Trend: Advancements In Oncology Treatment Tourism Enhancing Precision Care For Late-Stage Cancer Patients • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Oncology Treatment Tourism Market?

Oncology treatment tourism refers to the travel of patients across international borders to receive specialized cancer treatments, including Chemotherapy, radiotherapy, surgery, immunotherapy, and personalized care. This sector combines high-quality medical care with travel and hospitality services, enabling patients to access advanced oncology treatment options that may not be available or affordable in their home countries. It offers patients access to cutting-edge therapies while often providing cost-effective and timely solutions. The main treatment types of oncology treatment tourism include chemotherapy, radiation therapy, immunotherapy, targeted therapy, surgical oncology, and other types. Chemotherapy is a treatment method that uses drugs to destroy or slow the growth of cancer cells in the body. They find patient profiles such as adults, pediatrics, and geriatrics, and are used by several booking channels through direct booking, online platforms, and Medical Tourism agencies. They are provided by hospitals, specialty clinics, cancer centers, and other services.

What Is The Oncology Treatment Tourism Market Growth Forecast?

The oncology treatment tourism market size is expected to see rapid growth in the next few years. It will grow to $11.54 billion in 2030 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to increasing adoption of personalized oncology therapies, expansion of international insurance coverage for cross-border care, growing investment in specialized cancer centers, rising demand for shorter treatment waiting times, increasing collaborations between global healthcare providers. Major trends in the forecast period include rising cross-border access to advanced cancer therapies, growing demand for cost-effective oncology treatments, expansion of international cancer centers of excellence, increasing partnerships between hospitals and medical tourism agencies, rising preference for integrated treatment and hospitality packages.

Global Oncology Treatment Tourism Market Segmentation

1) By Treatment Type: Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy, Surgical Oncology, Other Treatment Types 2) By Patient Profile: Adults, Pediatrics, Geriatrics 3) By Booking Channel: Direct, Online Platforms, Medical Tourism Agencies 4) By Service Provider: Hospitals, Specialty Clinics, Cancer Centers, Other Services Subsegments: 1) By Chemotherapy: Adjuvant Chemotherapy, Neoadjuvant Chemotherapy, Palliative Chemotherapy, Combination Chemotherapy 2) By Immunotherapy: Immune Checkpoint Inhibitor Therapy, Monoclonal Antibody Therapy, Cancer Vaccine Therapy, Adoptive Cell Transfer Therapy 3) By Radiation Therapy: External Beam Radiation Therapy, Intensity Modulated Radiation Therapy, Image Guided Radiation Therapy, Brachytherapy 4) By Targeted Therapy: Small Molecule Targeted Therapy, Monoclonal Antibody Targeted Therapy, Angiogenesis Inhibitor Therapy, Hormone Targeted Therapy 5) By Surgical Oncology: Minimally Invasive Surgery, Robotic Assisted Surgery, Open Cancer Surgery, Cytoreductive Surgery 6) By Other Treatment Types: Hormone Therapy, Stem Cell Transplantation, Hyperthermia Therapy, Photodynamic Therapy

What Is The Driver Of The Oncology Treatment Tourism Market?

The increasing prevalence of cancer is expected to propel the growth of the oncology treatment tourism market going forward. Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body, which can invade surrounding tissues and metastasize to distant organs. The rise in cancer prevalence is attributed to aging populations, as older individuals have a higher risk of accumulating genetic mutations that can lead to cancer. Oncology treatment tourism supports cancer patients by providing access to advanced therapies, specialized oncologists, and innovative treatment protocols that may not be readily available in their home countries. It helps reduce treatment costs and waiting times while offering comprehensive care packages, improving accessibility, continuity of care, and overall treatment outcomes. For instance, in February 2024, according to the World Health Organization, a Switzerland-based international organization, over 35 million new cancer cases are predicted in 2050, a 77% increase from the 20 million cases in 2022. Therefore, the increasing prevalence of cancer is driving the growth of the oncology treatment tourism industry.

Key Players In The Global Oncology Treatment Tourism Market

Major companies operating in the oncology treatment tourism market are Mayo Clinic, Memorial Sloan Kettering Cancer Center, Cleveland Clinic, Johns Hopkins Medicine, Apollo Hospitals, Charité-Universitätsmedizin Berlin, Sheba Medical Center, Dana-Farber Cancer Institute, The Royal Marsden Hospital, Seoul National University Hospital, Clínica Universidad de Navarra, Karolinska University Hospital, Institut Curie, Istituto Nazionale dei Tumori, Asan Medical Center, Netherlands Cancer Institute, The Christie NHS Foundation Trust, Cancer Institute Hospital of JFCR, HCG Cancer Centre, Princess Margaret Cancer Centre, MD Anderson Cancer Center.

Global Oncology Treatment Tourism Market Trends and Insights

Major companies operating in the oncology treatment tourism market are focusing on developing advanced solutions, such as advanced oncology therapeutics, to enhance precision treatment and clinical outcomes for late-stage cancer patients. Advanced oncology therapeutics refers to a class of innovative medical treatments designed to target cancer at the molecular, cellular, or genetic level. For instance, in September 2025, Booking Health, a Germany-based medical travel facilitator, expanded its services to improve international access to advanced stage 4 cancer treatments, including immunotherapy, CAR T-cell therapy, and theranostics. The platform offers comprehensive coordination for patients, covering second opinions, personalized treatment plans, travel logistics, and follow-up care. By connecting patients with top-certified German hospitals such as LMU Klinikum, these services enable access to cutting-edge oncology options like HIPEC, PIPAC, and radioembolization (Y-90), which are designed to improve survival outcomes, enhance treatment precision, and support patient-centered cancer care.

What Are Latest Mergers And Acquisitions In The Oncology Treatment Tourism Market?

In January 2024, PureHealth, a United Arab Emirates-based integrated healthcare provider, acquired Circle Health Group for approximately $1.2 billion. With this acquisition, PureHealth aims to expand its international hospital network and strengthen access to advanced oncology and specialty care services for cross-border patients seeking treatment in the UK. Circle Health Group is a UK-based private hospital company providing oncology treatment services to international patients.

Regional Insights

North America was the largest region in the oncology treatment tourism market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Oncology Treatment Tourism Market?

The oncology treatment tourism market includes revenues earned by entities through medical consultation, treatment planning, hospital services, accommodation arrangements, travel coordination, post-treatment follow-ups, and personalized patient care. The market value includes the value of related goods and services sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data And Analysis Are Included In The Oncology Treatment Tourism Market Report 2026?

The oncology treatment tourism market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the oncology treatment tourism industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.